MRD Monitoring in Acute Lymphoblastic Leukemia
0 Vues
administrator
06/15/23
In this segment, Raoul Tibes, MD, PhD, discusses risk stratification based on minimal residual disease monitoring in patients with acute lymphoblastic leukemia achieve remission.
Montre plus
Commentaires de Facebook
Aucun commentaire trouvé